FibroScan
FibroScan
A FibroScan is a non-invasive diagnostic device that uses Transient Elastography (TE) technology to measure liver stiffness and assess liver fibrosis and fatty liver disease. It provides a quick, painless, and reliable alternative to liver biopsy for evaluating liver health.
Key Specifications (Typical)
- Technology: Transient Elastography (TE)
- Measurement Parameter: Liver Stiffness and Controlled Attenuation Parameter (CAP)
- Examination Time: Typically 5–10 minutes
- Procedure Type: Non-invasive and painless
- Results: Immediate quantitative assessment
- Liver Stiffness Range: Expressed in kilopascals (kPa)
- Fat Quantification: CAP score for hepatic steatosis assessment
- Patient Position: Supine (lying down)
- Data Storage: Digital patient records and reporting
- Applications: Liver fibrosis and fatty liver evaluation
Common Clinical Uses
- Assessment of liver fibrosis
- Detection and monitoring of fatty liver disease (NAFLD/NASH)
- Evaluation of chronic hepatitis B and C
- Monitoring of liver cirrhosis
- Follow-up of liver disease treatment
- Pre-treatment and post-treatment liver assessment
Advantages Over Liver Biopsy
- Completely non-invasive
- Painless and rapid procedure
- Immediate results
- No hospitalization required
- Repeatable for regular monitoring
- Reduced risk of complications
- High patient comfort and acceptance
Examples of FibroScan Systems
- FibroScan® Compact
- FibroScan® 430 Mini+
- FibroScan® Expert Series
Typical Benefits
- Early detection of liver fibrosis
- Accurate monitoring of chronic liver diseases
- Reliable assessment of fatty liver conditions
- Improved patient compliance
- Fast clinical decision-making
- Cost-effective alternative to invasive diagnostic procedures